Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Phase I/II Study to Evaluate the Effects of Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients With Biochemical Relapse

NCT00879619 is registered in ClinicalTrials.gov with John P. Fruehauf as lead sponsor.

NCT NCT00879619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00879619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Phase I/II Study to Evaluate the Effects of Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients With Biochemical Relapse
Lead sponsor
John P. Fruehauf
Phase
Phase 1/2
Overall status
Terminated
Start date
July 31, 2009
Completion date
November 30, 2011
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate, prostate cancer, recurrent prostate cancer, stage i prostate cancer, stage iii prostate cancer, stage iv prostate cancer